Molecular and clinicopathological analysis of dermatofibrosarcoma protuberans

Pathology Research and Practice

Volumn 209, Issue 1, 2013, Pages 30-35

  Walluks, Kassandra ^a   Chen, Yuan ^a   Woelfel, Cornelius ^a   Yang, Linlin ^a   Cui, Tiantian ^a   Seliger, Claudia ^a   Geier, Christiane ^a   Knösel, Thomas ^a   Hauke, Sven ^b   Petersen, Iver ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b ZytoVision GmbH   (Germany)

Author keywords

Amplification; Dermatofibrosarcoma protuberans; FISH; Multiplex RT PCR

Indexed keywords

COLLAGEN TYPE 1; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR;

ADULT; AGED; ARTICLE; CANCER GROWTH; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; CLINICAL FEATURE; COL1A1 GENE; CONTROLLED STUDY; DERMATOFIBROSARCOMA PROTUBERANS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE DOSAGE; GENE FUSION; GENE REARRANGEMENT; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MOLECULAR DYNAMICS; MORPHOLOGY; MULTIPLEX POLYMERASE CHAIN REACTION; PDGBFB GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED, 80 AND OVER; COLLAGEN TYPE I; DERMATOFIBROSARCOMA; FEMALE; GENE AMPLIFICATION; GENES, SIS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; MULTIPLEX POLYMERASE CHAIN REACTION; ONCOGENE PROTEINS, FUSION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84872425841     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2012.10.005     Document Type: Article

References (26)

1. Gloster H.M. Dermatofibrosarcoma protuberans. J. Am. Acad. Dermatol. 1996, 35:355-374. quiz 375-6.
2. Mentzel T., Beham A., Katenkamp D., Dei Tos A.P., Fletcher C.D. Fibrosarcomatous (" high-grade") dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance. Am. J. Surg. Pathol. 1998, 22:576-587.
3. Bowne W.B., Antonescu C.R., Leung D.H., Katz S.C., Hawkins W.G., Woodruff J.M., et al. Dermatofibrosarcoma protuberans: a clinicopathologic analysis of patients treated and followed at a single institution. Cancer 2000, 88:2711-2720.
4. Taylor H.B., Helwig E.B. Dermatofibrosarcoma protuberans. A study of 115 cases. Cancer 1962, 15:717-725.
5. Fiore M., Miceli R., Mussi C., Lo Vullo S., Mariani L., Lozza L., et al. Dermatofibrosarcoma protuberans treated at a single institution: a surgical disease with a high cure rate. J. Clin. Oncol. 2005, 23:7669-7675.
6. Simon M.P., Pedeutour F., Sirvent N., Grosgeorge J., Minoletti F., Coindre J.M., et al. Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma. Nat. Genet. 1997, 15:95-98.
7. Rutkowski P., Debiec-Rychter M., Nowecki Z., Michej W., Symonides M., Ptaszynski K., et al. Treatment of advanced dermatofibrosarcoma protuberans with imatinib mesylate with or without surgical resection. J. Eur. Acad. Dermatol. Venereol. 2011, 25:264-270.
8. Kutzner H., Mentzel T., Palmedo G., Hantschke M., Rutten A., Paredes B.E., et al. Plaque-like CD34-positive dermal fibroma (" medallion-like dermal dendrocyte hamartoma"): clinicopathologic, immunohistochemical, and molecular analysis of 5 cases emphasizing its distinction from superficial, plaque-like dermatofibrosarcoma protuberans. Am. J. Surg. Pathol. 2010, 34:190-201.
9. Takahira T., Oda Y., Tamiya S., Higaki K., Yamamoto H., Kobayashi C., et al. Detection of COL1A1-PDGFB fusion transcripts and PDGFB/PDGFRB mRNA expression in dermatofibrosarcoma protuberans. Mod. Pathol. 2007, 20:668-675.
10. Sirvent N., Maire G., Pedeutour F. Genetics of dermatofibrosarcoma protuberans family of tumors: from ring chromosomes to tyrosine kinase inhibitor treatment. Genes. Chromosomes Cancer 2003, 37:1-19.
11. Macarenco R.S., Zamolyi R., Franco M.F., Nascimento A.G., Abott J.J., Wang X., et al. Genomic gains of COL1A1-PDFGB occur in the histologic evolution of giant cell fibroblastoma into dermatofibrosarcoma protuberans. Genes. Chromosomes Cancer 2008, 47:260-265.
12. O'Brien K.P., Seroussi E., Dal Cin P., Sciot R., Mandahl N., Fletcher J.A., et al. Various regions within the alpha-helical domain of the COL1A1 gene are fused to the second exon of the PDGFB gene in dermatofibrosarcomas and giant-cell fibroblastomas. Genes. Chromosomes Cancer 1998, 23:187-193.
13. Wang J., Hisaoka M., Shimajiri S., Morimitsu Y., Hashimoto H. Detection of COL1A1-PDGFB fusion transcripts in dermatofibrosarcoma protuberans by reverse transcription-polymerase chain reaction using archival formalin-fixed, paraffin-embedded tissues. Diagn. Mol. Pathol. 1999, 8:113-119.
14. Sheng W.Q., Hashimoto H., Okamoto S., Ishida T., Meis-Kindblom J.M., Kindblom L.G., et al. Expression of COL1A1-PDGFB fusion transcripts in superficial adult fibrosarcoma suggests a close relationship to dermatofibrosarcoma protuberans. J. Pathol. 2001, 194:88-94.
15. Giacchero D., Maire G., Nuin P.A., Berthier F., Ebran N., Carlotti A., et al. No correlation between the molecular subtype of COL1A1-PDGFB fusion gene and the clinico-histopathological features of dermatofibrosarcoma protuberans. J. Invest. Dermatol. 2010, 130:904-907.
16. Kerob D., Pedeutour F., Leboeuf C., Verola O., de Kerviler E., Servant J.M., et al. Value of cytogenetic analysis in the treatment of dermatofibrosarcoma protuberans. J. Clin. Oncol. 2008, 26:1757-1759.
17. Wang J., Morimitsu Y., Okamoto S., Hisaoka M., Ishida T., Sheng W., et al. COL1A1-PDGFB fusion transcripts in fibrosarcomatous areas of six dermatofibrosarcomas protuberans. J. Mol. Diagn. 2000, 2:47-52.
18. Salgado R., Llombart B.R.M.P., Fernandez-Serra A., Sanmartin O., Toll A., et al. Molecular diagnosis of dermatofibrosarcoma protuberans: a comparison between reverse transcriptase-polymerase chain reaction and fluorescence in situ hybridization methodologies. Genes. Chromosomes Cancer 2011, 50:510-517.
19. Patel K.U., Szabo S.S., Hernandez V.S., Prieto V.G., Abruzzo L.V., Lazar A.J., et al. Dermatofibrosarcoma protuberans COL1A1-PDGFB fusion is identified in virtually all dermatofibrosarcoma protuberans cases when investigated by newly developed multiplex reverse transcription polymerase chain reaction and fluorescence in situ hybridization assays. Hum. Pathol. 2008, 39:184-193.
20. Shimizu A., O'Brien K.P., Sjoblom T., Pietras K., Buchdunger E., Collins V.P., et al. The dermatofibrosarcoma protuberans-associated collagen type Ialpha1/platelet-derived growth factor (PDGF) B-chain fusion gene generates a transforming protein that is processed to functional PDGF-BB. Cancer Res. 1999, 59:3719-3723.
21. Simon M.P., Navarro M., Roux D., Pouyssegur J. Structural and functional analysis of a chimeric protein COL1A1-PDGFB generated by the translocation t(17;22)(q22;q13.1) in Dermatofibrosarcoma protuberans (DP). Oncogene 2001, 20:2965-2975.
22. McArthur G. Molecularly targeted treatment for dermatofibrosarcoma protuberans. Semin. Oncol. 2004, 31:30-36.
23. Maki R.G., Awan R.A., Dixon R.H., Jhanwar S., Antonescu C.R. Differential sensitivity to imatinib of 2 patients with metastatic sarcoma arising from dermatofibrosarcoma protuberans. Int. J. Cancer 2002, 100:623-626.
24. Labropoulos S.V., Fletcher J.A., Oliveira A.M., Papadopoulos S., Razis E.D. Sustained complete remission of metastatic dermatofibrosarcoma protuberans with imatinib mesylate. Anticancer Drugs 2005, 16:461-466.
25. Mizutani K., Tamada Y., Hara K., Tsuzuki T., Saeki H., Tamaki K., et al. Imatinib mesylate inhibits the growth of metastatic lung lesions in a patient with dermatofibrosarcoma protuberans. Br. J. Dermatol. 2004, 151:235-237.
26. Rutkowski P., Van Glabbeke M., Rankin C.J., Ruka W., Rubin B.P., Debiec-Rychter M., et al. Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials. J. Clin. Oncol. 2010, 28:1772-1779.